Sprayable chitosan nanogel with nitric oxide to accelerate diabetic wound healing through bacteria inhibition, biofilm eradication and macrophage polarization

Int J Biol Macromol. 2024 Jan;254(Pt 1):127806. doi: 10.1016/j.ijbiomac.2023.127806. Epub 2023 Oct 31.

Abstract

Bacterial infection and chronic inflammation are two major risks in diabetic wound healing, which increase patient mortality. In this study, a multifunctional sprayable nanogel (Ag-G@CS) based on chitosan has been developed to synergistically inhibit bacterial infection, eradicate biofilm, and relieve inflammation of diabetic wounds. The nanogel is successfully crafted by encapsulating with a nitric oxide (NO) donor and performing in-situ reduction of silver nanoparticles (Ag). The released NO enhances the antibacterial efficacy of Ag, nearly achieving complete eradication of biofilms in vitro. Upon application on both normal or diabetic chronic wounds, the combination effects of released NO and Ag offer a notable antibacterial effect. Furthermore, after bacteria inhibition and biofilm eradication, the NO released by the nanogel orchestrates a transformation of M1 macrophages into M2 macrophages, significantly reducing tumor necrosis factor α (TNF-α) release and relieving inflammation. Remarkably, the released NO also promotes M2a to M2c macrophages, thereby facilitating tissue remodeling in chronic wounds. More importantly, it upregulates the expression of vascular endothelial growth factor (VEGF), further accelerating the wound healing process. Collectively, the formed sprayable nanogel exhibits excellent inhibition of bacterial infections and biofilms, and promotes chronic wound healing via inflammation resolution, which has excellent potential for clinical use in the future.

Keywords: Antibacterial activity; Biofilm eradication; Diabetic wound healing; Macrophages polarization; Nitric oxide.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacteria
  • Bacterial Infections*
  • Biofilms
  • Chitosan* / pharmacology
  • Diabetes Mellitus, Experimental* / metabolism
  • Humans
  • Inflammation
  • Macrophages
  • Metal Nanoparticles*
  • Nanogels
  • Nitric Oxide / pharmacology
  • Silver / pharmacology
  • Vascular Endothelial Growth Factor A / pharmacology
  • Wound Healing

Substances

  • Chitosan
  • Nitric Oxide
  • polyethylene glycol polyethyleneimine nanogel
  • Nanogels
  • Vascular Endothelial Growth Factor A
  • Silver
  • Anti-Bacterial Agents